Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity -Schedule of Warrant Activity (Details)

v3.21.1
Stockholders' Equity -Schedule of Warrant Activity (Details)
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Equity [Abstract]  
Shares Underlying Warrants Outstanding, Beginning | shares 3,501,014
Shares Underlying Warrants Granted | shares 3,873,711
Shares Underlying Warrants Exercised | shares (13,642)
Shares Underlying Warrants Outstanding, Ending | shares 7,361,083
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 8.03
Weighted Average Exercise Price Granted | $ / shares 7.24
Weighted Average Exercise Price Exercised | $ / shares 7.33
Weighted Average Exercise Price Outstanding, Ending | $ / shares $ 7.62
Weighted Average Remaining Contractual Life, Beginning 2 years 10 months 14 days
Weighted Average Remaining Contractual Life, Ending 2 years 6 months 25 days